RECURSION PHARMACEUTICALS INC financial statements, including revenue, expenses, and profit
The total revenue of RXRX for the last quarter is 94.78 M MXN, and it's 81.56% lower compared to the previous quarter. The net income of Q4 24 is -3.73 B MXN.